LYMPHOSEEK (Norgine Pty Ltd)
Product name
LYMPHOSEEK
Sponsor
Date registered
Evaluation commenced
Decision date
Approval time
197 working days (255)
Active ingredients
tilmanocept
Registration type
NCE/NBE
Indication
This medicinal product is for diagnostic use only
Radiolabelled LYMPHOSEEK is indicated for imaging and intraoperative detection of sentinel lymph nodes draining a primary tumour in adult patients with breast cancer, melanoma, or localised squamous cell carcinoma of the oral cavity. External imaging and intraoperative evaluation may be performed using a gamma detection device.